 Lymphoma, Follicular
"Lymphoma, Follicular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.
| Descriptor ID |
D008224
|
| MeSH Number(s) |
C04.557.386.480.350 C15.604.515.569.480.350 C20.683.515.761.480.350
|
| Concept/Terms |
Lymphoma, Follicular- Lymphoma, Follicular
- Follicular Lymphomas
- Lymphomas, Follicular
- Follicular Lymphoma
- Lymphoma, Nodular
- Lymphomas, Nodular
- Nodular Lymphoma
- Nodular Lymphomas
- Giant Follicular Lymphoma
- Lymphoma, Giant Follicular
- Brill-Symmers Disease
- Brill Symmers Disease
- Disease, Brill-Symmers
- Follicular Lymphoma, Giant
- Follicular Lymphomas, Giant
- Giant Follicular Lymphomas
- Lymphomas, Giant Follicular
Lymphoma, Small Cleaved-Cell, Follicular- Lymphoma, Small Cleaved-Cell, Follicular
- Small Follicular Center-Cell Lymphoma
- Small Follicular Center Cell Lymphoma
- Lymphocytic Lymphoma, Nodular, Poorly Differentiated
- Lymphoma, Small Lymphoid, Follicular
- Lymphoma, Lymphocytic, Nodular, Poorly Differentiated
- Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated
- Lymphoma, Small Cleaved Cell, Follicular
- Lymphoma, Small Follicular Center-Cell
- Lymphoma, Small Follicular Center Cell
- Small Cleaved-Cell Lymphoma, Follicular
- Small Cleaved Cell Lymphoma, Follicular
- Lymphocytic Lymphoma, Nodular, Poorly-Differentiated
Lymphoma, Large-Cell, Follicular- Lymphoma, Large-Cell, Follicular
- Nodular Large Follicular Center-Cell Lymphoma
- Nodular Large Follicular Center Cell Lymphoma
- Follicular Large-Cell Lymphoma
- Follicular Large Cell Lymphoma
- Follicular Large-Cell Lymphomas
- Large-Cell Lymphomas, Follicular
- Lymphomas, Follicular Large-Cell
- Histiocytic Lymphoma, Nodular
- Histiocytic Lymphomas, Nodular
- Lymphoma, Nodular Histiocytic
- Lymphomas, Nodular Histiocytic
- Nodular Histiocytic Lymphoma
- Nodular Histiocytic Lymphomas
- Lymphoma, Nodular, Large Follicular Center Cell
- Large-Cell Lymphoma, Follicular
- Large Cell Lymphoma, Follicular
- Lymphoma, Follicular Large-Cell
- Lymphoma, Follicular Large Cell
- Lymphoma, Histiocytic, Nodular
- Lymphoma, Large Cell, Follicular
- Lymphoma, Large Lymphoid, Nodular
- Lymphoma, Nodular, Large Follicular Center-Cell
- Large Lymphoid Lymphoma, Nodular
Lymphoma, Mixed-Cell, Follicular- Lymphoma, Mixed-Cell, Follicular
- Lymphoma, Follicular, Mixed Cell
- Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic
- Lymphoma, Follicular, Mixed Small and Large Lymphoid
- Lymphoma, Follicular, Small and Large Cleaved-Cell
- Lymphoma, Nodular, Mixed Lymphocytic Histiocytic
- Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic
- Lymphoma, Nodular, Mixed Small and Large Cell
- Mixed-Cell Lymphoma, Follicular
- Mixed Cell Lymphoma, Follicular
- Follicular Mixed-Cell Lymphoma
- Follicular Mixed Cell Lymphoma
- Follicular Mixed-Cell Lymphomas
- Lymphoma, Follicular Mixed-Cell
- Lymphomas, Follicular Mixed-Cell
- Mixed-Cell Lymphomas, Follicular
- Lymphoma, Follicular, Small and Large Cleaved Cell
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Follicular".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Follicular".
This graph shows the total number of publications written about "Lymphoma, Follicular" by people in this website by year, and whether "Lymphoma, Follicular" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2006 | 3 | 0 | 3 | | 2007 | 2 | 0 | 2 | | 2009 | 0 | 1 | 1 | | 2010 | 2 | 1 | 3 | | 2011 | 1 | 0 | 1 | | 2012 | 3 | 0 | 3 | | 2013 | 3 | 0 | 3 | | 2014 | 2 | 0 | 2 | | 2015 | 3 | 1 | 4 | | 2016 | 2 | 0 | 2 | | 2017 | 4 | 0 | 4 | | 2019 | 7 | 0 | 7 | | 2020 | 3 | 0 | 3 | | 2021 | 3 | 2 | 5 | | 2022 | 1 | 0 | 1 | | 2023 | 1 | 0 | 1 | | 2024 | 2 | 0 | 2 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoma, Follicular" by people in Profiles.
-
Mondello P, Negaard B, Feldman AL, Link BK, Casulo C, Chihara D, Russler-Germain D, Romancik J, Gribbin C, Haddadi S, Mou E, Micallef IN, Johnston PB, Novak J, Wang Y, King RL, Novak AJ, Habermann TM, Martin P, Kahl B, Nowakowski GS, Nastoupil LJ, Cerhan JR, Flowers CR, Lossos IS, Burack RW, Maurer MJ, Ansell SM. Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts. Blood Cancer J. 2025 Aug 08; 15(1):134.
-
Iqbal M, Kumar A, Dreger P, Chavez J, Sauter CS, Sureda AM, Bachanova V, Maziarz RT, Dreyling M, Smith SM, Jacobson C, Glass B, Casulo C, Oluwole OO, Montoto S, Advani R, Cohen J, Salles G, Hamad N, Kuruvilla J, Kahl BS, Shadman M, Kanate AS, Budde LE, Kamdar M, Flowers C, Hamadani M, Kharfan-Dabaja MA. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation. Transplant Cell Ther. 2024 09; 30(9):832-843.
-
Morschhauser F, Dahiya S, Palomba ML, Martin Garcia-Sancho A, Reguera Ortega JL, Kuruvilla J, Jäger U, Cartron G, Izutsu K, Dreyling M, Kahl B, Ghesquieres H, Ardeshna K, Goto H, Barbui AM, Abramson JS, Borchmann P, Fleury I, Mielke S, Skarbnik A, de Vos S, Kamdar M, Karmali R, Viardot A, Farazi T, Fasan O, Lymp J, Vedal M, Nishii R, Avilion A, Papuga J, Kumar J, Nastoupil LJ. Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nat Med. 2024 Aug; 30(8):2199-2207.
-
Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE, Christian B, DeVos S, Dholaria B, Fayad LE, Habermann TM, Hamid MS, Hernandez-Ilizaliturri F, Hu B, Kaminski MS, Karimi Y, Kelsey CR, King R, Krivacic S, LaCasce AS, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023. J Natl Compr Canc Netw. 2023 11; 21(11):1118-1131.
-
Meric-Bernstam F, Beeram M, Hamilton E, Oh DY, Hanna DL, Kang YK, Elimova E, Chaves J, Goodwin R, Lee J, Nabell L, Rha SY, Mayordomo J, El-Khoueiry A, Pant S, Raghav K, Kim JW, Patnaik A, Gray T, Davies R, Ozog MA, Woolery J, Lee KW. Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study. Lancet Oncol. 2022 12; 23(12):1558-1570.
-
Phillips T, Chan H, Tam CS, Tedeschi A, Johnston P, Oh SY, Opat S, Eom HS, Allewelt H, Stern JC, Tan Z, Novotny W, Huang J, Trotman J. Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma. Blood Adv. 2022 06 14; 6(11):3472-3479.
-
Desai SH, LaPlant B, Macon WR, King RL, Wang Y, Inwards DJ, Micallef I, Johnston PB, Porrata LF, Ansell SM, Habermann TM, Witzig TE, Nowakowski GS. Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study. Blood Cancer J. 2021 09 25; 11(9):160.
-
Do KT, Chow LQM, Reckamp K, Sanborn RE, Burris H, Robert F, Camidge DR, Steuer CE, Strickler JH, Weise A, Specht JM, Gutierrez M, Haughney P, Hengel S, Derleth CL, Yap TA. First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. Oncologist. 2021 11; 26(11):925-e1918.
-
Barreto JN, Bansal R, Hathcock MA, Doleski CJ, Hayne JR, Truong TA, Nedved AN, Ansell SM, Bennani NN, Paludo J, Villasboas JC, Lin Y, Johnston PB. The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy. Am J Hematol. 2021 10 01; 96(10):E399-E402.
-
Kleinschmidt-DeMasters BK, Gilani A. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type. Ann Diagn Pathol. 2021 Aug; 53:151765.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|